ISRCTN10171652已完成不适用
A double blind, randomised, placebo controlled trial investigating the efficacy and role of Synbiotic Cocktail 2000 in the treatment of Clostridium difficile diarrhoea and colitis
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 120 人开始时间: 2003年9月12日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Any patient with a stool sample positive for Toxin A and clinically symptomatic in the Trust will be offered entry into the trial.
- •ASSESSMENT ON ADMISSION INTO TRIAL:
- •1. History and physical examination
- •2. Blood tests
- •3. Stool analysis for C. difficile and Toxin A
- •4. Rigid or flexible sigmoidoscopy with biopsies
排除标准
- •Patients may be removed from the study if one or more of the following occurs:
- •1. Protocol violation or non-compliance on part of the patient
- •2. Refusal of the patient to continue treatment and a decision by the investigator that termination is in the patient's best medical interest (or a significant unrelated medical illness or complication)
研究者
相似试验
终止
3 期
Melatonin to improve induction of labour: a double blind, randomised, placebo controlled trial.ACTRN12616000311459Monash Health187
进行中（未招募）
1 期
A double blind, randomised, placebo controlled trial of the time to onset meaningful of pain relief in subjects with post herpetic neuralgia (PHN) treated with pregabalin (150-600 mg /day flexible optimised dose or 300 mg/day fixed dose) or placebo - n/aEUCTR2004-002563-24-ESPFIZER, S.A.255
进行中（未招募）
1 期
A double blind, randomised, placebo controlled trial to study the clinical effectiveness of Angiotensin Converting Enzyme (ACE) inhibitors, ramipril,in patients with intermittent claudication - ACE Inhibitor Clinical Effectiveness in ClaudicantsIntermittent ClaudicationEUCTR2009-016600-23-GBHull and East Yorkshire Hospitals NHS Trust
进行中（未招募）
1 期
A double blind, randomised, placebo controlled trial of the time to onset of meaningful pain relief in subjects with post herpetic neuralgia (PHN) treated with pregabalin (150-600 mg /day flexible optimised dose or 300 mg/day fixed dose) or placebo - n/apost herpetic neuralgiaMedDRA version: 7Level: LLTClassification code 10036376EUCTR2004-002563-24-GBPfizer Ltd255
已完成
3 期
Randomised control trial of monoamine precursors for the treatment of psychostimulant withdrawalACTRN12607000094471Sydney South West Area Health Service100